Rituximab plus ASHAP for the treatment of patients with relapsed or refractory aggressive non-Hodgkin’s lymphoma: a single-centre study of 20 patients

2007 ◽  
Vol 86 (4) ◽  
pp. 271-276 ◽  
Author(s):  
Semra Aydin ◽  
Ulrich Dührsen ◽  
Holger Nückel
Keyword(s):  
Hodgkin’S Lymphoma ◽  
Hodgkin's Lymphoma ◽  
Single Centre ◽  
Centre Study ◽  
Non Hodgkin’S Lymphoma ◽  
Non Hodgkin's Lymphoma ◽  
Single Centre Study

Chlorambucil-rituximab as first-line therapy in patients affected by follicular non-Hodgkin's lymphoma: a retrospective single-centre study

2014 ◽  
Vol 33 (4) ◽  
pp. 129-135 ◽  
Author(s):  
Giovanni Martinelli ◽  
Juan Montoro ◽  
Anna Vanazzi ◽  
Giovanna Andreola ◽  
Sarah Liptrott ◽  
...  
Keyword(s):  
Hodgkin’S Lymphoma ◽  
Hodgkin's Lymphoma ◽  
First Line ◽  
Single Centre ◽  
Centre Study ◽  
First Line Therapy ◽  
Line Therapy ◽  
Non Hodgkin’S Lymphoma ◽  
Non Hodgkin's Lymphoma ◽  
Single Centre Study

Ophthalmologic and intraocular non-Hodgkin's lymphoma: a large single centre study of initial characteristics, natural history, and prognostic factors

2004 ◽  
Vol 22 (4) ◽  
pp. 143-158 ◽  
Author(s):  
Jérôme Meunier ◽  
Livia Lumbroso-Le Rouic ◽  
Anne Vincent-Salomon ◽  
Rémy Dendale ◽  
Bernard Asselain ◽  
...  
Keyword(s):  
Prognostic Factors ◽  
Natural History ◽  
Hodgkin’S Lymphoma ◽  
Hodgkin's Lymphoma ◽  
Single Centre ◽  
Centre Study ◽  
Non Hodgkin’S Lymphoma ◽  
Non Hodgkin's Lymphoma ◽  
Single Centre Study
Sign in / Sign up

Export Citation Format

Share Document